Cargando…

Propensity Score-Based Approaches in High Dimension for Pharmacovigilance Signal Detection: an Empirical Comparison on the French Spontaneous Reporting Database

Classical methods used for signal detection in pharmacovigilance rely on disproportionality analysis of counts aggregating spontaneous reports of a given adverse drug reaction. In recent years, alternative methods have been proposed to analyze individual spontaneous reports such as penalized multipl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Courtois, Émeline, Pariente, Antoine, Salvo, Francesco, Volatier, Étienne, Tubert-Bitter, Pascale, Ahmed, Ismaïl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153352/ https://www.ncbi.nlm.nih.gov/pubmed/30279658 http://dx.doi.org/10.3389/fphar.2018.01010

Ejemplares similares

New adaptive lasso approaches for variable selection in automated pharmacovigilance signal detection
por: Courtois, Émeline, et al.
Publicado: (2021)

Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database
por: Létinier, Louis, et al.
Publicado: (2021)

Estimating time-to-onset of adverse drug reactions from spontaneous reporting databases
por: Leroy, Fanny, et al.
Publicado: (2014)

Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine Learning
por: Courtois, Émeline, et al.
Publicado: (2022)

French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge
por: Lacroix, Clémence, et al.
Publicado: (2021)

Validation study: evaluation of the metrological quality of French hospital data for perinatal algorithms
por: Goueslard, Karine, et al.
Publicado: (2020)

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
por: Berthet, Stephanie, et al.
Publicado: (2011)

Trends in psychotropic drug consumption among French military personnel during the COVID-19 epidemic
por: Sanchez, Marc-Antoine, et al.
Publicado: (2022)

Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
por: Schweitzer-Chaput, Arnaud, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor-Related Cytopenias: About 68 Cases from the French Pharmacovigilance Database
por: Martin, Mickaël, et al.
Publicado: (2022)

COVID-19 and social inequalities: a complex and dynamic interaction
por: Quantin, Catherine, et al.
Publicado: (2022)

Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
por: Valnet-Rabier, Marie-Blanche, et al.
Publicado: (2023)

Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database
por: Allouchery, Marion, et al.
Publicado: (2021)

Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres
por: Gras-Champel, Valérie, et al.
Publicado: (2021)

Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance database
por: Garon-Czmil, Julie, et al.
Publicado: (2019)

Temporal Asthma Patterns Using Repeated Questionnaires over 13 Years in a Large French Cohort of Women
por: Sanchez, Margaux, et al.
Publicado: (2013)

Adverse effects of gender‐affirming hormonal therapy in transgender persons: Assessing reports in the French pharmacovigilance database
por: Yelehe, Melissa, et al.
Publicado: (2022)

Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
por: Salvo, Francesco, et al.
Publicado: (2023)

Instrumental variable analysis in the context of dichotomous outcome and exposure with a numerical experiment in pharmacoepidemiology
por: Koladjo, Babagnidé François, et al.
Publicado: (2018)

Accounting for indirect protection in the benefit–risk ratio estimation of rotavirus vaccination in children under the age of 5 years, France, 2018
por: Escolano, Sylvie, et al.
Publicado: (2020)

Selection of genes for gene-environment interaction studies: a candidate pathway-based strategy using asthma as an example
por: Rava, Marta, et al.
Publicado: (2013)

French Pharmacovigilance Public System and COVID-19 Pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020)

Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022
por: Bihan, Kevin, et al.
Publicado: (2023)

Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database
por: Thai-Van, Hung, et al.
Publicado: (2023)

Drug-Induced Acute Kidney Injury: A Study from the French Medical Administrative and the French National Pharmacovigilance Databases Using Capture-Recapture Method
por: Rolland, Anne-Lise, et al.
Publicado: (2021)

A benefit–risk analysis of rotavirus vaccination, France, 2015
por: Lamrani, Adnane, et al.
Publicado: (2017)

Leveraging the Variability of Pharmacovigilance Disproportionality Analyses to Improve Signal Detection Performances
por: Khouri, Charles, et al.
Publicado: (2021)

Potential and Pitfalls of Pharmacovigilance Databases in Oncology
por: Schlam, Ilana, et al.
Publicado: (2023)

Systematising Pharmacovigilance Engagement of Patients, Healthcare Professionals and Regulators: A Practical Decision Guide Derived from the International Risk Governance Framework for Engagement Events and Discourse
por: Bahri, Priya, et al.
Publicado: (2021)

Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions
por: Karapetiantz, Pierre, et al.
Publicado: (2018)

Matching methods to create paired survival data based on an exposure occurring over time: a simulation study with application to breast cancer
por: Savignoni, Alexia, et al.
Publicado: (2014)

Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
por: Martin, Guillaume L., et al.
Publicado: (2022)

A Pharmacovigilance Study on the Safety of Axicabtagene Ciloleucel Based on Spontaneous Reports from the EudraVigilance Database
por: Rafaniello, Concetta, et al.
Publicado: (2023)

Global determinants of mortality in under 5s: 10 year worldwide longitudinal study
por: Hanf, Matthieu, et al.
Publicado: (2013)

Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database
por: Scanvion, Quentin, et al.
Publicado: (2020)

Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database
por: Billioti de Gage, Sophie, et al.
Publicado: (2018)

Allergens labeling on French processed foods – an Oqali study
por: Battisti, Charlène, et al.
Publicado: (2017)

P1135: EFFECT OF GLUCARPIDASE RESCUE IN PATIENTS WITH HIGH-DOSE METHOTREXATE INDUCED ACUTE KIDNEY INJURY: A FRENCH PHARMACOVIGILANCE DATABASE STUDY
por: Pierre, Sabrina, et al.
Publicado: (2023)

Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011–2016
por: Maura, Géric, et al.
Publicado: (2019)

Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting
por: Hadi, Muhammad Abdul, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_memtlpam6m9e2dpdicdltdqmd2